Therapeutic effect of SN50, an inhibitor of nuclear factor-κB, in treatment of TBI in mice
- PMID: 22437493
- DOI: 10.1007/s10072-012-1007-z
Therapeutic effect of SN50, an inhibitor of nuclear factor-κB, in treatment of TBI in mice
Abstract
NF-κB upregulation has been demonstrated in neurons and glial cells in response to experimental injury and neuropathological disorders, where it has been related to both neurodegenerative and neuroprotective activities. It has been generally recognized that NF-κB plays important roles in the regulation of apoptosis and inflammation as well as innate and adaptive immunity. However, the regulatory mechanism of NF-κB in apoptosis remained to be determined. The present study sought to first investigate the effect of a NF-κB inhibitor SN50, which inhibits NF-κB nuclear translocation, on cell death and behavioral deficits in our mice traumatic brain injury (TBI) models. Additionally, we tried to elucidate the possible mechanisms of the therapeutic effect of SN50 through NF-κB regulating apoptotic and inflammatory pathway in vivo. Encouragingly, the results showed that pretreatment with SN50 remarkably attenuated TBI-induced cell death (detected by PI labeling), cumulative loss of cells (detected by lesion volume), and motor and cognitive dysfunction (detected by motor test and Morris water maze). To analyze the mechanism of SN50 on cell apoptotic and inflammatory signaling pathway, we thus assessed expression levels of TNF-α, cathepsin B and caspase-3, Bid cleavage and cytochrome c release in SN50-pretreated groups compared with those in saline vehicle groups. The results imply that through NF-κB/TNF-α/cathepsin networks SN50 may contribute to TBI-induced extrinsic and intrinsic apoptosis, and inflammatory pathways, which partly determined the fate of injured cells in our TBI model.
Similar articles
-
Cathepsin B in neurodegeneration of Alzheimer's disease, traumatic brain injury, and related brain disorders.Biochim Biophys Acta Proteins Proteom. 2020 Aug;1868(8):140428. doi: 10.1016/j.bbapap.2020.140428. Epub 2020 Apr 17. Biochim Biophys Acta Proteins Proteom. 2020. PMID: 32305689 Free PMC article. Review.
-
Cathepsin B contributes to traumatic brain injury-induced cell death through a mitochondria-mediated apoptotic pathway.J Neurosci Res. 2010 Oct;88(13):2847-58. doi: 10.1002/jnr.22453. J Neurosci Res. 2010. PMID: 20653046
-
Inhibitor of nuclear factor-κB, SN50, attenuates lipopolysaccharide-induced lung injury in an isolated and perfused rat lung model.Transl Res. 2014 Mar;163(3):211-20. doi: 10.1016/j.trsl.2013.10.002. Epub 2013 Oct 12. Transl Res. 2014. PMID: 24646628
-
Mitochondrial division inhibitor 1 (Mdivi-1) offers neuroprotection through diminishing cell death and improving functional outcome in a mouse model of traumatic brain injury.Brain Res. 2016 Jan 1;1630:134-43. doi: 10.1016/j.brainres.2015.11.016. Epub 2015 Nov 17. Brain Res. 2016. PMID: 26596858
-
NF-kB's contribution to B cell fate decisions.Front Immunol. 2023 Jul 18;14:1214095. doi: 10.3389/fimmu.2023.1214095. eCollection 2023. Front Immunol. 2023. PMID: 37533858 Free PMC article. Review.
Cited by
-
The double stranded RNA analog poly-IC elicits both robust IFN-λ production and oncolytic activity in human gastrointestinal cancer cells.Oncotarget. 2018 Oct 2;9(77):34471-34484. doi: 10.18632/oncotarget.26121. eCollection 2018 Oct 2. Oncotarget. 2018. PMID: 30349642 Free PMC article.
-
Switching off key signaling survival molecules to switch on the resolution of inflammation.Mediators Inflamm. 2014;2014:829851. doi: 10.1155/2014/829851. Epub 2014 Jul 17. Mediators Inflamm. 2014. PMID: 25136148 Free PMC article. Review.
-
Cathepsin B in neurodegeneration of Alzheimer's disease, traumatic brain injury, and related brain disorders.Biochim Biophys Acta Proteins Proteom. 2020 Aug;1868(8):140428. doi: 10.1016/j.bbapap.2020.140428. Epub 2020 Apr 17. Biochim Biophys Acta Proteins Proteom. 2020. PMID: 32305689 Free PMC article. Review.
-
Modulators of HIF1α and NFkB in Cancer Treatment: Is it a Rational Approach for Controlling Malignant Progression?Front Pharmacol. 2013 Feb 12;4:13. doi: 10.3389/fphar.2013.00013. eCollection 2013. Front Pharmacol. 2013. PMID: 23408731 Free PMC article.
-
Resolution of Inflammation: What Controls Its Onset?Front Immunol. 2016 Apr 26;7:160. doi: 10.3389/fimmu.2016.00160. eCollection 2016. Front Immunol. 2016. PMID: 27199985 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous